Ibrucent

Sobre este medicamento

Originator: Imbruvica by Pharmacyclics · Manufacturer: Incepta Pharma. Indication & Dosage: Ibrucent (Ibrutinib), generic Imbruvica is a prescription medicine used to treat certain cancers such as Mantle cell lymphoma (MCL), Chronic lymphocytic leukemia (CLL)/ small lymphocytic lymphoma, Marginal zone lymphoma (MZL), Waldenstrom macroglobulinemia, Chronic graft-versus-host (cGVHD) disease. Ibrucent manufactured by Incepta Pharma Ltd. in Bangladesh. Ibrutinib has to take orally once daily with a glass of water. Side Effects: The most common adverse reactions of Ibrutinib are: Thrombocytopenia, diarrhea , neutropenia , anemia , fatigue , musculoskeletal pain , peripheral edema, upper respiratory tract infection, nausea , bruising, dyspnea, constipation, skin rash, abdominal pain, vomiting , and loss of appetite. The above information comes from the Internet. Please consult with doctor for medical advice.

Esta información es solo de referencia y no constituye consejo médico. Consulte siempre a un profesional de la salud calificado.